PATENT CLAIM ANALYSIS

Application Number: 16044582
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-12
Patent Classification: ["424", "085400"]

Abstract:
The invention provides a method and/or composition for the treatment of bone cancer including primary bone cancer and secondary bone cancer, breast cancer, skin cancer, nasopharyngeal carcinoma, oral cancer, vulva cancer, prostate cancer, cervical cancer, melanoma including melanocarcinoma by percutaneous and/or transmucosal administration of the interferon. Further, the invention provides a method and/or composition for the treatment of skin, subcutaneous, mucosal and/or submucosal primary cancer and cancer metastatic lesions by percutaneous and/or transmucosal administration of the interferon, especially a method and/or composition for the treatment of bone cancer pain including pain resulted by secondary bone cancer.

Claim (Index 185):
The method of  claim 182 , wherein application of interferon to the mucosa comprises application to the mucosa in proximity to the bone affected by cancer, or application to the mucosa surrounding the bone affected by cancer.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 95.0
- Lexical Diversity: 2.55814
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13535291', '14656397', '09794531', '15748284', '14661656']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6895876804031578
- 35 USC 102 Novelty (BERT): 0.5080953083734767
- Combined Prediction Score: 0.6714384432001896
- Mean Citation Score: 202.414172
- Max Citation Score: 206.80763
- Similarity Product: 126.38773966491163

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test